title: Parvovirus arthropathy outbreak in southwestern United States.
abstract: OBJECTIVE
  We describe an outbreak of parvovirus (PV) arthropathy that was detected in a rheumatology clinic in San Antonio, Texas, during the winter of 1994. Parvovirus B19 causes acute symmetric polyarthritis (ASPA) in adults. In the US, the majority of cases described are from the northern US.
  
  
  METHODS
  An outbreak of PV arthropathy was monitored in a San Antonio area rheumatology clinic.
  
  
  RESULTS
  Of the 16 affected patients, 69% were female, ages ranging from 23 to 60 years; 75% had close contact with children, 58% of whom were exposed to children with clinical PV. All patients noted an acute arthritis except for 2 patients with polyarthralgias. The most common presentation was ASPA (9/16), with 10/16 complaining of viral prodrome, and 5/16 having a nonspecific rash, but none with the typical "slapped cheek" appearance. Eleven patients had an ASPA at some time in their illness. Of these, 3 had a true migratory arthritis that developed into an ASPA and another 2 were additive. Two additional patients had persistent asymmetric polyarthritis. The most common joints involved were the metacarpophalangeals, proximal interphalangeals, wrists, and knees. Most patients' syndromes lasted < 6 weeks, but 3 patients had symptoms that lasted longer than 6 months. Eight of 10 had elevated erythrocyte sedimentation rate. Rheumatoid factor was detected in 3 patients and antinuclear antibody in 2. All patients were treated symptomatically with nonsteroidal antiinflammatory drugs and a few also received low dose corticosteroids. Because of suspicious clinical presentations, 2 patients were presumed to have gonococcal arthritis before PV titers were available.
  
  
  CONCLUSIONS
  This is the first large series on adults with PV arthropathy reported in the southern US. In contrast to the usual features of ASPA, the outbreak appears unique in that almost 40% of cases presented with a true migratory arthritis.
authors.affiliation: Department of Internal Medicine, Keesler Air Force Base, Mississippi, USA. dscroggie@hotmail.com
authors.forename: D A
authors.initials: DA
authors.lastname: Scroggie
authors.forename: M T
authors.initials: MT
authors.lastname: Carpenter
authors.forename: R I
authors.initials: RI
authors.lastname: Cooper
authors.forename: J B
authors.initials: JB
authors.lastname: Higgs
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood; D000914:Antibodies, Viral / Q000276:immunology; D000956:Antigens, Viral / Q000097:blood; D001170:Arthritis, Infectious / Q000097:blood / Q000453:epidemiology* / Q000209:etiology; D001799:Blood Sedimentation; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007596:Joints / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010322:Parvoviridae Infections / Q000097:blood / Q000150:complications / Q000453:epidemiology*; D017992:Parvovirus / Q000276:immunology / Q000302:isolation & purification*; D012189:Retrospective Studies; D012217:Rheumatoid Factor / Q000097:blood; D015206:Southwestern United States / Q000453:epidemiology
chemical_list: D000974:Antibodies, Antinuclear; D000914:Antibodies, Viral; D000956:Antigens, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012217:Rheumatoid Factor